TheEdgeResearch
Home / Stocks / BOIRF

Boiron S.A. (BOIRF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$31.50 ▲ +0.00%
Market Cap
$546.9M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.22
52-Wk Range
24-32.28
CEO
Thierry Boiron
Country
FR
Currency
USD

Boiron S.A. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Messimy, FR. The stock last traded at $31.50, up 0.00% on the session, giving a market capitalisation of $546.9M. On trailing twelve-month figures it carries a trailing P/E of 14.25, a net margin of 6.5%. Its beta of 0.22 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
14.25
Price / Sales
0.92
Price / Book
1.19
EV / EBITDA
6.22
Gross margin
73.0%
Operating margin
7.1%
Net margin
6.5%
Return on equity
Debt / equity
0.08
Current ratio
2.22
Dividend yield
5.1%
Payout ratio
63.8%
Company profile
Exchange
Other OTC
Employees
2,634
IPO date
1996-05-02
Headquarters
Messimy, FR
About Boiron S.A.

Boiron S.A. is a leading pharmaceutical enterprise focused on the global development and sale of homeopathic treatments. Its market presence extends across France, the wider European continent, North America, and numerous international territories. The company's offerings comprise a diverse array of homeopathic products, including both non-proprietary and branded formulations. Notable examples from its brand portfolio target specific health concerns: Oscillococcinum is formulated to alleviate symptoms associated with influenza, such as fever, chills, headaches, and general body aches. Stodal and Stodaline are designed for the symptomatic relief of coughs. Arnigel provides topical support for minor, non-open traumatic injuries. Camilia is specifically developed to soothe teething discomfort in infants. Sédatif PC addresses anxiety, emotional imbalances, and mild sleep disturbances. Coryzalia helps manage cold symptoms and rhinitis. Homéoptic offers relief for various types of eye irritation and discomfort in both adults and children. Homéovox is aimed at vocal disorders. Beyond its core homeopathic line, Boiron provides a range of supplementary health products. These include dietary supplements; the Dermoplasmine collection (available as stick, balm, and mousse) for dry lips and skin; Mag' Nuit, designed to aid sleep; Arnitrosium for joint pain; Castor Equi Boiron ointment to treat cracked skin; and Storinil, a syrup for cold treatment. Furthermore, the company produces herbal medicines, such as Canephron, which supports increased urine production and improved urinary elimination. Its product list also features moisturizing baby milk and a selection of medical devices, including COVID-19 self-tests and rapid antigenic tests. Boiron distributes its extensive product portfolio through a wide network, encompassing its own distribution centers, independent pharmacies, large pharmacy chains, wholesalers, grocery stores, specialized health food retailers, and online sales platforms. Established in 1932, Boiron S.A. maintains its corporate headquarters in Messimy, France.

Comparable companies

Boiron S.A. is most often compared with the following Healthcare names:

AGYTFBJTRFCLVSFELTPGLASFMNFSFSWDCFTRXPFVRNOFYIHCF
More research on BOIRF
BOIRF technical analysis BOIRF TheEdge Score Compare against peers
Open full interactive analysis & DCF →